Cases of Severe Malaria and Cerebral Malaria in Apam Catholic Hospital and Manhiya District Hospital

Similar documents
Malaria DR. AFNAN YOUNIS

Risk of malaria in Pregnancy and under-five (5) children in densely populated communities in Kumasi, Ghana

Case Definitions of Clinical Malaria under Different Transmission Conditions in Kilifi District, Kenya

Copenhagen, Denmark, September August Malaria

Invest in the future, defeat malaria

Target Product Profile: Point-of-Care Malaria Plasmodium falciparum Highly Sensitive Rapid Diagnostic Test

Malaria. Edwin J. Asturias, MD

MALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY

Mass drug Administration When Is It Useful

Addressing Malaria in Pregnancy: A Comprehensive Approach to Maternal and Newborn Health Outcomes

Gradual acquisition of immunity to severe malaria with increasing

public facility in the same area context of AMFm

Malaria Parasitaemia in Children With Protein Energy Malnutrition In North Central Nigeria: A Case Control Study.

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

PARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia)

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1

A study of the prevalence of malaria and typhoid fever co-infection in Abakaliki, Nigeria

Interpretation of the World Malaria Report Country Profile

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Driving access to medicine

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Watersheds of the African Continent

Comparison of light microscopy and nested PCR assay in detecting of malaria mixed species infections in an endemic area of Iran

Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar

Key Messages for World Malaria Day 2009

38 Current Concepts in

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:

INTERVENTION MODEL OF MALARIA

New insights into the epidemiology of malaria relevant for disease control

A comparative clinical trial of artemether and quinine in Cerebral Malaria

HIV and Malaria Interactions

Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018

Summary World Malaria Report 2010

Running head: VECTOR-BORNE DISEASE 1

Parasite Burden and Severity of Malaria in Tanzanian Children

Increase in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and North East Africa

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

Hospitalization Criteria in Imported Falciparum Malaria

Malaria Burden Estimation Evidence Review Group (MBE-ERG)

Revised Strategy for Malaria Control in the South-East Asia Region

Enhancing Immunogenicity of Recombinant Vaccines: Chemical Conjugation

Crude health statistics

Evolution of Virulence: Malaria, a Case Study Prof. Andrew F. Read

Spotting Malaria reliably

Pelagia Research Library. European Journal of Experimental Biology, 2013, 3(5):

Media centre Malaria. Key facts. Symptoms

Measuring the path toward malaria elimination

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Distribution of Plasmodium falciparum

Severe Anemia in Young Children After High and Low Malaria Transmission Seasons in the Kassena- Nankana District of Northern Ghana

Epidemiology and control profile of malaria in. Sierra Leone 2017 Supplement

Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries

Malaria in London: Review of imported malaria cases. Data from 2000 to 2012

Where are we with Malaria in Africa?

The President s Malaria Initiative (PMI) Indoor Residual Spraying (IRS) in Motion: Malaria Stories from the Field

THE EFFECTS OF HAEMOGLOBINOPATHIES AND G6PD DEFICIENCY ON MALARIA AMONG CHILDREN OF THE KINTAMPO NORTH MUNICIPALITY OF GHANA

BRIEFING ON RTS,S/AS01 MALARIA VACCINE FOR THE SEPTEMBER 2012 MEETING OF MPAC

Health care related factors associated with severe malaria in children in Kampala, Uganda

Kath Maitland Imperial College London & KEMRI / Wellcome Trust Programme, Kilifi, Kenya

to change size? Abstract Introduction

College of Alternative Medicine, Ghana Abstract

Malaria. Dr Zia-Ul-Ain Sabiha

In several African countries in sub-saharan Africa, malaria is the leading cause of death in children under five.

Analytical evaluation of Malaria Research Papers in MEDLINE & SCI during the period of &

Eliminating malaria in SWAZILAND

Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas

Malaria screening of donors and donations - issues and outcomes

Malaria. Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania

Evaluation of Malaria Surveillance System in Hooghly district of West Bengal - India

Ph.D. Thesis: Protective immune response in P.falciparum malaria 2011 CHAPTER I: Introduction. S.D. Lourembam 16

in control group 7, , , ,

Pacifica, Pilot Synod, 2011

ISSN X (Print) Original Research Article. DOI: /sjams India

Malaria: Prevention remains our best measure for controlling the disease

Clinico-epidemiological profile of malaria: Analysis from a primary health centre in Karnataka, Southern India GJMEDPH 2012; Vol.


Malaria Rapid Diagnostic Tests

FACTS. Approximately 2.48 million malaria cases are reported annually from South Asia. Of Which 75% cases are contributed by India alone.

40% (90% (500 BC)

Eliminating malaria in BOTSWANA

Journal Assignment #2. Malaria Epidemics throughout the World

The specter of malaria that resists treatment

Department of Clinical Medicine, School of Medicine and Health Sciences, Kabarak University; Kenya

Chemoprophylaxis and intermittent treatment for preventing malaria in children (Review)

Proposed Evidence Review Group on assessment of malariogenic potential to inform elimination strategies and plans to prevent re-establishment

Modelling the Epidemiology of Malaria: A Case Study of Wassa West District in the Western Region of Ghana

A Local, Regional, and National Assessment of Pediatric Malaria in the United States

Epidemiology of hepatitis E infection in Hong Kong

Monitoring and Evaluation Reference Group (MERG) GUIDANCE NOTE

Ethiopia Malaria Financial Landscape

Tanzania s Progress in Combating Malaria: Achievement and Challenges

Implementing the Abuja Declaration and Plan of Action: the journey so far

COMPARISON OF BLOOD SMEAR MICROSCOPY TO A RAPID DIAGNOSTIC TEST FOR IN-VITRO TESTING FOR P. FALCIPARUM MALARIA IN KENYAN SCHOOL CHILDREN

Prevalence of malaria from peripheral blood smears examination: A 1-year retrospective study from the Serbo Health Center, Kersa Woreda, Ethiopia

Evidence Review Group on MDA, MSAT and FSAT Malaria Policy Advisory Committee Geneva, Switzerland September 2015

Journal of Natural Science, Engineering and Technology * 1 O.A IDOWU, 1 SAMUEL OGUNDEYI, 1 S.O SAM-WOBO AND 2 E. FABUSORO

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

Ideas for Educating Clinicians Ideas for Future Clinical Trials

Malaria: A Global Perspective and Prospects for Elimination. Rima Shretta

Evidence to Recommendation Table 1

Epidemiological trends of malaria in an endemic district Tumkur, Karnataka

Transcription:

Cases of Severe Malaria and Cerebral Malaria in Apam Catholic Hospital and Manhiya District Hospital CL Barba, MSIV Charles Drew University of Medicine and Science Los Angeles, CA

QUESTION What pediatric age group does malaria affect the most? A) 0-2 B) 3-6 C) 7-10 D) 11-14 E) 15-18

BACKGROUND Malaria is an illness with a heavy global impact, killing an estimated 2.7 million people annually worldwide. Despite years of research on malaria, there is much to be learned about the human immune response to Plasmodium falciparum and Plasmodium vivax.

BACKGROUND (cont.) Malaria is still one of the leading causes of death in Ghana In Ghana, over 40% of outpatient cases and over 60% of hospital admissions are due to malaria

METHODS Data was collected from pediatric medical records at Apam Catholic hospital and Manhiya District Hospital from November 2007 through April 2008 Only cases of severe and cerebral malaria were recorded The age, sex, and disease (severe malaria or cerebral malaria) were also recorded for those months

METHODS: Study Design Find Admission Records Collect data only on severe and cerebral malaria Collect data on age, sex, and disease Collected 73 cases Cases collected within the last 6 months Information gets inputted into a database

DEMOGRAPHICS Gender Percentages 47% 53% Male Female

Percentage of all children with Severe or Cerebral Malaria 23% Severe Malaria 77% Cerebral Malaria

Ages of children with Severe or Cerebral Malaria 60% 50% 40% 30% 20% 10% 0% 58% 23% 12% 4% 3% 0-2 3-6 7-10 11-14 15-18 Age in Years

60% 50% 40% 30% 20% 10% 0% Ages of children with Severe Malaria versus Cerebral Malaria 42% 12% 18% 5% 7% 5% 3% 1% 3% 0% 0-2 3-6 7-10 11-14 15-18 Age in Years Severe Malaria Cerebral Malaria

Gender Breakdown for Both Severe and Cerebral Malaria 60% 40% 20% 0% 44% Male 9% 33% Female 14% Severe Malaria Age in Cerebral Years Malaria

CONCLUSIONS Pediatric children from ages 0-2 have the highest propensity to get cerebral or severe malaria. As the ages of the patients increased the incidence of cerebral and severe malaria decreased greatly. This trend could be explained by a natural or "induced" immunity. Many studies have shown that people living in endemic areas of malaria with extremely high transmission rates develop a natural immunity to infection

CONCLUSIONS (cont.) The current philosophy on induced immunity is upheld by the Malaria Immunity Paradigm (MIP), established via studies in areas of intense malaria transmission, mainly in sub-saharan Africa The MIP upholds that induced immunity is difficult to achieve and is dependent upon frequent bouts of malaria for each individual within a given year. As defined by the MIP, the more transmission is intense and regular within a population, the higher the prevalence of asymptomatic infections indicative of clinical immunity

IMPLICATIONS We need to be able to comprehend what factors go into natural or induced immunity in order to construct a vaccine A vaccine to children, especially in the 0-5 age group range, would be greatly beneficial in reducing malaria morbidity and mortality Malaria prevention include insecticides, insecticide treated nets, closed gutters, prophylaxis (for travelers), and as discussed before vaccines

PROBLEMS Resistance to insecticides; a lot of families do not have nets, and failure to develop an effective vaccine Resistance to treatment; The introduction of artemisinin based combinations may reverse that trend, but resistance to these drugs will evolve eventually It is crucial to establish and maintain close surveillance as new drugs are introduced so that they will have the maximum useful therapeutic life

LIMITATIONS Records at Apam and Manhiya were not always the most reliable. In both cases sometimes cerebral malaria was listed as just severe malaria. Small sample size to accurately predict such an endemic disease. Study only took into account two hospitals in Ghana. The data collection period was only 6 months.

QUESTION What pediatric age group does malaria affect the most? A) 0-2 B) 3-6 C) 7-10 D) 11-14 E) 15-18

QUESTION What pediatric age group does malaria affect the most? A) 0-2 B) 3-6 C) 7-10 D) 11-14 E) 15-18

REFERENCES 1. Carter, R., and Mendis, K.N. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 15: 564-594. 2002. 2. Marsh, Kevin, Snow RW. Host-Parasite Interaction and Morbidity in Malaria Endemic Areas. Philosophical Transactions: Biological Sciences 352(1359): 1385-1394. 2005. 3. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349: 1650-1654. 1997. 4. Bottius E, Guanzirolli A, Trape JF, Rogier C et. al. "Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitemia detectable by the polymerase chain reaction." Trans R. Soc Trop Med Hyg 90 (1): 9-15. 1996. 5. Reyburn Hugh, Mbatia Redempta et. al. Association of Transmission Intensity and Age with Clinical Manifestations and Case Fatality of Severe Plasmodium falciparum Malaria. JAMA 293 (12): 1461-1470. 2005. 6. Mgobo, CN, Snow RW et. al. "Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast." Am. J Trop Med Hyg 49(2): 245-253. 1993. 7. Colbourne, M.J. Malaria in gold Coast students on their return from the United Kingdom. Trans R Soc Trop Med Hyg 49:483-487. 1955. 8. Greenwood, B.M. 1984. The impact of malaria chemoprophylaxis on the immune status of Africans. Bull World Health Organ 62:69-75. 1984.

ACKNOWLEGMENTS I would like to thank the staff at Apam Catholic Hospital and Manhiya District Hospital for all their help and for the great experiences I had. I would also like to thank GE and NMF for funding and coordinating this fellowship and allowing us to have such a life changing experience. THANK YOU